Efficacy and Safety of Simvastatin in the Treatment of Portal Hypertension
Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effects of continuous simvastatin administration
on the hepatic venous pressure gradient (HVPG), as a surrogate marker of prognosis, and its
safety in patients with cirrhosis and portal hypertension.